Multidrug resistance in Salmonella enterica serotype Typhimurium from humans in France (1993 to 2003)

Journal of Clinical Microbiology
François-Xavier WeillPatrick A D Grimont

Abstract

The aim of this study was to determine the distribution of the antimicrobial resistance phenotypes (R types), the phage types and XbaI-pulsed-field gel electrophoresis (PFGE) types, the genes coding for resistance to beta-lactams and to quinolones, and the class 1 integrons among a representative sample of Salmonella enterica serotype Typhimurium isolates collected from humans in 2002 through the French National Reference Center for Salmonella (NRC-Salm) network. The trends in the evolution of antimicrobial resistance of serotype Typhimurium were reviewed by using NRC-Salm data from 1993, 1997, 2000, and 2003. In 2002, 3,998 isolates of serotype Typhimurium were registered at the NRC-Salm among 11,775 serotyped S. enterica isolates (34%). The most common multiple antibiotic resistance pattern was resistance to amoxicillin, chloramphenicol, streptomycin and spectinomycin, sulfonamides, and tetracycline (ACSSpSuTe R type), with 156 isolates (48.8%). One isolate resistant to extended-spectrum cephalosporins due to the production of TEM-52 extended-spectrum beta-lactamase was detected (0.3%), and one multidrug-resistant isolate was highly resistant to ciprofloxacin (MIC > 32 mg/liter). We found that 57.2% of the isolates tested bel...Continue Reading

References

Apr 1, 1977·The Journal of Hygiene·E S AndersonJ D de Sa
Jan 1, 1995·Antimicrobial Agents and Chemotherapy·C LévesqueP H Roy
Oct 1, 1995·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·P HeisigJ P Faber
Jul 3, 1998·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·A Ridley, E J Threlfall
Oct 8, 1999·Emerging Infectious Diseases·P S MeadR V Tauxe
Jul 7, 2000·The Journal of Antimicrobial Chemotherapy·E J Threlfall
Jan 14, 2003·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Sylvie BaucheronAxel Cloeckaert
Mar 13, 2003·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·E.J. ThrelfallB Rowe
Jun 25, 2003·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·E J ThrelfallK Speed
Jun 25, 2003·Antimicrobial Agents and Chemotherapy·Minggui WangDavid C Hooper
Dec 25, 2003·Antimicrobial Agents and Chemotherapy·R Bonnet
Mar 30, 2004·Antimicrobial Agents and Chemotherapy·M DalyS Fanning
Apr 14, 2004·Emerging Infectious Diseases·Po-Ren HsuehKwen-Tay Luh
Jun 15, 2004·International Journal of Antimicrobial Agents·V MiriagouL S Tzouvelekis
Jun 18, 2004·Emerging Infectious Diseases·Therese Rabatsky-EhrUNKNOWN NARMS Working Group
Jul 10, 2004·Journal of Clinical Microbiology·François-Xavier WeillPatrick A D Grimont
Oct 27, 2004·Antimicrobial Agents and Chemotherapy·Tersia KrugerDavid L Paterson
Mar 9, 2005·Molecular Microbiology·Benoît DoubletAxel Cloeckaert
Apr 26, 2005·International Journal of Antimicrobial Agents·Katie L HopkinsE John Threlfall
May 26, 2005·The Journal of Antimicrobial Chemotherapy·A MurrayD J Brown
Jun 21, 2005·Emerging Infectious Diseases·Morten HelmsUNKNOWN DT104 Study Group

❮ Previous
Next ❯

Citations

Dec 12, 2012·Tropical Animal Health and Production·Jorge Antonio Varela-GuerreroJesús Vázquez-Guadarrama
Aug 6, 2009·Epidemiology and Infection·E I BroughtonC L Coles
Sep 22, 2007·Foodborne Pathogens and Disease·Annaëlle KérouantonAnne Brisabois
Oct 14, 2009·Foodborne Pathogens and Disease·Rungtip ChuanchuenSukuma Samngamnim
Apr 16, 2011·Foodborne Pathogens and Disease·Lu RanJay K Varma
Feb 24, 2012·Foodborne Pathogens and Disease·Xiaoling DengJay K Varma
Jul 27, 2007·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Svetlana EgorovaFrançois-Xavier Weill
Oct 28, 2009·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Sueli A FernandesYohei Doi
Nov 6, 2008·The Journal of Antimicrobial Chemotherapy·Shenghui CuiYue Ma
Oct 29, 2010·Proceedings. Biological Sciences·M J DenwoodS W J Reid
Aug 31, 2007·Journal of Clinical Microbiology·Thi Anh Hong LeFrançois-Xavier Weill
Nov 3, 2010·The Journal of Veterinary Medical Science·Luca BorrelliLudovico Dipineto
May 25, 2012·PloS One·Laëtitia FabreFrançois-Xavier Weill
Dec 21, 2006·Emerging Infectious Diseases·François-Xavier WeillPatrick A D Grimont
Jan 1, 2009·Emerging Infectious Diseases·Eva Møller NielsenAnette M Hammerum
Jan 20, 2012·Emerging Infectious Diseases·Simon Le HelloFrançois-Xavier Weill
Jun 19, 2015·Folia Microbiologica·Yolande T R ProrogaVincenzo Pasquale
Sep 2, 2015·International Journal of Food Microbiology·Manuela MurgiaBianca Paglietti
Feb 12, 2009·Journal of Medical Microbiology·Malini R CapoorParukutty Pillai
Nov 4, 2008·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Marina Macedo-ViñasRafael Vignoli
Feb 18, 2010·Molecular Cell·Michael A KohanskiJames J Collins
May 1, 2010·Genetics, Selection, Evolution : GSE·Fanny CalengeCatherine Beaumont
Dec 25, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·R CantónT M Coque
Feb 17, 2009·Enfermedades infecciosas y microbiología clínica·María Del Carmen MendozaMaría Rosario Rodicio
Aug 17, 2018·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Muhammad WajidAamir Ali
Apr 5, 2013·Clinical Microbiology Reviews·Anna Fàbrega, Jordi Vila
Sep 14, 2007·Scandinavian Journal of Infectious Diseases·Mohammad R PourshafieSalvatore Rubino

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.